The TPD52L2 Polyclonal Antibody (PAC012861) is a valuable tool for researchers studying TPD52L2, a protein involved in cancer progression and metastasis. This antibody, produced in rabbits, demonstrates high specificity and sensitivity when used on human samples, making it a reliable choice for various research applications.TPD52L2, also known as tumor protein D52-like 2, is implicated in cell growth, survival, and migration, making it a key player in oncogenesis. By targeting TPD52L2 with this antibody, researchers can accurately detect and analyze the protein in different cell types, enabling a deeper understanding of its function in cancer biology.
The significance of TPD52L2 in cancer development highlights the importance of further research in this area, with the potential for uncovering new therapeutic targets and treatment strategies. By utilizing the TPD52L2 Polyclonal Antibody, researchers can advance their understanding of cancer biology and potentially contribute to the development of novel cancer therapies.
tumor protein D52-like 2;TPD52L2;D54;DKFZp686A1765;hD54 ;
UniProt Protein Function:
UniProt Protein Details:
NCBI Summary:
This gene encodes a member of the tumor protein D52-like family. These proteins are characterized by an N-terminal coiled-coil motif that is used to form homo- and heteromeric complexes with other tumor protein D52-like proteins. Expression of this gene may be a marker for breast cancer and acute lymphoblastic leukemia. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene, and a pseudogene of this gene is located on the long arm of chromosome 12. [provided by RefSeq, Aug 2011]
